BI Asset Management Fondsmaeglerselskab A S Reduces Stake in Mettler-Toledo International, Inc. $MTD

BI Asset Management Fondsmaeglerselskab A S lessened its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 38.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,086 shares of the medical instruments supplier’s stock after selling 686 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Mettler-Toledo International were worth $1,370,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of MTD. Nordea Investment Management AB lifted its position in Mettler-Toledo International by 11.9% during the fourth quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock valued at $220,718,000 after purchasing an additional 16,777 shares during the period. Pensionfund Sabic purchased a new stake in Mettler-Toledo International in the fourth quarter valued at $1,255,000. M&T Bank Corp grew its position in Mettler-Toledo International by 2,813.6% during the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock worth $173,165,000 after purchasing an additional 119,942 shares during the period. Crossmark Global Holdings Inc. grew its position in Mettler-Toledo International by 34.3% during the 4th quarter. Crossmark Global Holdings Inc. now owns 4,150 shares of the medical instruments supplier’s stock worth $5,786,000 after purchasing an additional 1,060 shares during the period. Finally, Legal & General Group Plc raised its stake in shares of Mettler-Toledo International by 3.5% during the 3rd quarter. Legal & General Group Plc now owns 169,256 shares of the medical instruments supplier’s stock valued at $207,780,000 after buying an additional 5,672 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Wolfe Research began coverage on Mettler-Toledo International in a report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. JPMorgan Chase & Co. dropped their target price on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Stifel Nicolaus reduced their price target on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a research report on Monday, May 18th. Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Citigroup lowered their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Mettler-Toledo International has an average rating of “Hold” and a consensus target price of $1,408.55.

Mettler-Toledo International Stock Up 4.2%

Shares of Mettler-Toledo International stock opened at $1,204.66 on Thursday. The firm has a market cap of $24.35 billion, a PE ratio of 28.25, a P/E/G ratio of 2.41 and a beta of 1.27. Mettler-Toledo International, Inc. has a twelve month low of $1,023.05 and a twelve month high of $1,525.17. The business has a 50-day moving average price of $1,181.29 and a 200 day moving average price of $1,295.16.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The company had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. During the same quarter in the prior year, the business posted $8.19 earnings per share. Mettler-Toledo International’s revenue for the quarter was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, sell-side analysts expect that Mettler-Toledo International, Inc. will post 46.6 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.